CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Time Technoplast rises on getting nod for type-4 composite cylinders for onboard application

DSIJ Intelligence 0 757 Article rating: 3.3

Time Technoplast Limited announced on Wednesday after the market hours that Petroleum & Explosives Safety Organisation (PESO) formally notified its approval for type-4 composite cylinders for onboard application for the range of cylinders. Bureau Veritas has also confirmed its approval through a separate communication.

LETTER

Ninad Ramdasi 0 497 Article rating: No rating

I found your latest issue interesting because it highlighted investing opportunities in the PSU sector and also talked about some of the outstanding performances in the latest quarter.

Reviews

Ninad Ramdasi 0 508 Article rating: No rating

In this edition, we have reviewed Pfizer Limited. and Escorts Limited. We suggest our reader-investors to HOLD in Pfizer Limited and Escorts Limited

Query Board

Ninad Ramdasi 0 579 Article rating: No rating

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.

Data Bank & Dividend

Ninad Ramdasi 0 643 Article rating: No rating

This is a super house of financial data on 3500 corporates with up to date information. In the Magazine version the top 1100 -1400 companies are covered while the data on the entire 3500 companies is available in excel format for subscribers to download.

MF Query Board

Ninad Ramdasi 0 610 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved.

Fund of Fortnight

Ninad Ramdasi 0 455 Article rating: No rating

This is our mutual fund recommendation. Every fortnight , we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same

Stocks that are likely to record significant movement on bourses today

DSIJ Intelligence-3 0 671 Article rating: 4.4

Time Technoplast: The company is pleased to announce that Petroleum & Explosives Safety Organisation (PESO) formally notified its approval for type-4 composite cylinders for onboard application for the range of cylinders. Bureau Veritas has also confirmed its approval through a separate communication.  

Happiest Minds executes digital transformation project for Coca-Cola United; stock shines

Apurva Joshi 0 971 Article rating: 4.9

Happiest Minds Technologies Limited has informed the bourses that it has successfully executed a digital transformation project for Coca Cola Bottling Company United for streamlining its order management with robotic process automation (RPA) in Microsoft Power Automate. 

Join us for an exclusive interview with Mr Saransh Chaudhary, President, Critical Care Division, Venus Remedies

DSIJ Intelligence 0 1650 Article rating: 4.6

"Our top three strategic priorities include forging synergic partnerships for our leading generic & research products, optimising organisational leverage to maximise our gains as well as astute capital investment", says Mr Saransh Chaudhary, CEO, Venus Medicine Research Centre (VMRC), and President, Critical Care Division, Venus Remedies in an exclusive interview with Geyatee Deshpande, Senior Research Associate, Dalal Street Investment Journal.  

LTI solidifies presence in Nordic region via partnership with Sweden-based Hoist Finance

DSIJ Intelligence 0 1172 Article rating: 4.6

Larsen & Toubro Infotech (LTI), a global technology consulting & digital solutions company has entered into a strategic engagement with Hoist Finance AB, a pan European financial services company in the purchasing and management of non-performing & performing loan, to provide banking-as-a-service via its digital banking platform.  

Shares of Praj Industries surge on technology breakthrough to produce Bio-bitumen

DSIJ Intelligence 0 1592 Article rating: 3.9

The industrial biotech company, Praj Industries announced today that it has successfully developed innovative technology to produce Bio-bitumen based on lignin after Netherlands-based Circular Biobased Delta approved Praj’s Bio-bitumen samples processed from purified lignin. 

Shilpa Medicare joins hands with Dr Reddy's Laboratories for production-supply of Sputnik V vaccine

Apurva Joshi 0 655 Article rating: 4.9

Shilpa Medicare Limited via its wholly-owned subsidiary, Shilpa Biologicals Private Limited (SBPL) has entered into a three-year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of Sputnik V vaccine (used for COVID-19) from its integrated biologics R&D-cum-manufacturing centre at Dharwad (Karnataka).

Welspun India targets US markets with Target Corporation, board approves buyback & much more!

DSIJ Intelligence 0 852 Article rating: 4.7

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

Alembic Pharmaceuticals plunge despite getting USFDA nod for Lurasidone Hydrochloride tablets

DSIJ Intelligence 0 691 Article rating: 3.7

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).  

Dr Reddys rolls out Sputnik-V vaccine in Indian market; priced at Rs 948 per dose

DSIJ Intelligence 0 864 Article rating: 4.5

Dr Reddy’s Laboratories on Friday announced that the first consignment of imported doses of Sputnik-V vaccine was administered in Hyderabad today as part of a limited pilot soft-launch. The consignment of doses that landed in India on May 01, 2021, received regulatory clearance from Central Drugs Laboratory (CDL, Kasauli) on May 13, 2021.   

TCS launches cloud-based intelligent subscription solution for media & publishing industry

DSIJ Intelligence 0 735 Article rating: 4.9

Tata Consultancy Services (TCS), the leading global IT service, consulting & business solutions organisation announced that it has launched a cloud-based intelligent subscription solution by leveraging on the SAP business technology platform for the media & publishing industry.

Naveen Chandramohan, Founder & Fund Manager of ITUS Capital talks about market volatility

DSIJ Intelligence 0 1072 Article rating: 5.0

A good question for investors to handle volatility would be to ask themselves as to ‘what per cent of my financial exposure can suffer a 40 per cent fall and I can continue without panicking’. It is the question of how you react at a psychological level, rather than your age. 

RSS
First295296297298300302303304Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR